1YR企业会员
| 英文名称 | 中文名称 | CAS |
|---|---|---|
| (S)-AMPA | L-701,252 | 151057-13-5 |
| UCB-5307 | 化合物 UCB-5307 | 1515887-44-1 |
| UCB-9260 | UCB-9260 | 1515888-53-5 |
| Evocarpine | 吴茱萸卡品碱 | 15266-38-3 |
| PF-06454589 | CS-2879 | 1527473-30-8 |
| Rebamipide mofetil | 4-Quinolinepropanoic acid, α-[(4-chlorobenzoyl)amino]-1,2-dihydro-2-oxo-, 2-(4-morpholinyl)ethyl ester | 1527495-76-6 |
| c-Fms-IN-10 | c-Fms-IN-10 | 1527517-50-5 |
| BPI-9016M | BPI-9016M | 1528546-94-2 |
| Isolithocholic acid | 异石胆酸 | 1534-35-6 |
| Gavestinel sodium salt | GAVESTINEL | 153436-38-5 |
| Voxilaprevir | 维昔普维 | 1535212-07-7 |
| 2'-C-Methyladenosine | 2'-C-甲基腺苷 | 15397-12-3 |
| BIO-32546 | BIO-32546 | 1548743-66-3 |
| Autotaxin modulator 1 | 1548743-69-6 | 1548743-69-6 |
| Ibufenac | 异丁芬酸 | 1553-60-2 |
| IBT6A hydrochloride | 3-(4-苯氧基苯基)-1-(3R)-3-哌啶基-1H-吡唑并[3,4-D]嘧啶-4-胺盐酸盐(1:1) | 1553977-42-6 |
| Sofiniclin | BNC375 | 1557240-80-8 |
| Avitinib | 艾维替尼 | 1557267-42-1 |
| LE135 | LE 135 | 155877-83-1 |
| KG5 | 纳替尼-D8 | 1562993-37-6 |
| PARP1-IN-11 | G244-LM | 1563007-08-8 |
| HTH-01-091 TFA | MTI-31 | 1567915-38-1 |
| DBIBB | DBIBB | 1569309-92-7 |
| TAK1-IN-4 | 化合物HS220 | 1570374-32-1 |
| Tenofovir amibufenamide | 艾米替诺福韦 | 1571076-26-0 |
| MONNA | 2-(4-甲氧基萘-2-基氨基)-5-硝基苯甲酸 | 1572936-83-4 |
| PU139 | PU139 | 158093-65-3 |
| IT-901 | IT-901 | 1584121-99-2 |
| PSI | Z-异亮氨酰-叔丁基谷氨酰-丙氨酸-亮氨酸缩醛 | 158442-41-2 |
| Tankyrase-IN-2 | TANKYRASE-IN-2 | 1588870-36-3 |
| BRD0209 | 化合物 T26894 | 1597439-87-6 |
| Rodatristat | RODATRISTAT | 1673568-73-4 |
| Dimethoxycurcumin | DIMETHOXYCURCUMIN | 160096-59-3 |
| bio-THZ1 | bio-THZ1 | 1604811-14-4 |
| DY268 | DY 268 | 1609564-75-1 |
| Glicoricone | 甘草瑞酮 | 161099-37-2 |
| Tuvusertib | ATR INHIBITOR 1 | 1613200-51-3 |
| EIDD-2749 | 4'-C-Fluoro-uridine | 1613589-24-4 |
| Linsidomine hydrochloride | 5-氨基-3-(4-吗啉基)-1,2,3-恶二唑盐酸盐 | 16142-27-1 |
| PF-06372865 | PF-06372865 | 1614245-70-3 |
| Netoglitazone | MCC-555 | 161600-01-7 |
| Camlipixant | BLU-5937 | 1621164-74-6 |
| LY3177833 monhydrate | 化合物LY3143921 HYDRATE | 1627696-53-0 |
| SGK1-IN-4 | 化合物SGK1-IN-4 | 1628048-93-0 |
| IEM-1754 | IEM 1754 DIHYDROBROMIDE | 162831-31-4 |
| GNE-131 | CS-2887 | 1629063-81-5 |
| Oxymatrine | SRI011381 | 1629138-41-5 |
| CDK8-IN-1 | CDK8-IN-1 | 1629633-48-2 |
| (R)-DNMDP | (R)-DNMDP | 1630760-60-9 |
| KLH45 | KLH45 | 1632236-44-2 |
| 680C91 | 680C91 | 163239-22-3 |
| KA2507 | Benzamide, 4-[(di-2-pyrazinylamino)methyl]-N-hydroxy- | 1636894-46-6 |
| GS-626510 | GS-626510 | 1637770-13-8 |
| ABR-238901 | 化合物ABR-238901 | 1638200-22-2 |
| Nigericin | BAX ACTIVATOR-1 | 1638526-94-9 |
| JC124 | Benzamide, 5-chloro-2-methoxy-N-[2-[4-[(methylamino)sulfonyl]phenyl]ethyl]- | 1638611-48-9 |
| Salvianolic acid Y | Salvianolic acid Y | 1638738-76-7 |
| HSK0935 | HSK0935 | 1638851-44-1 |
| ARN14974 | ARN14974 | 1644158-57-5 |
| Iptacopan hydrochloride | 化合物LNP023 HYDROCHLORIDE | 1646321-63-2 |
| FD-IN-1 | FD-IN-1 | 1646682-14-5 |
| Epiblastin A | Epiblastin A | 16470-02-3 |
| Vomifoliol | CS-1661 | 1649450-12-3 |
| GSK121 | GSK121 (trifluoroacetate salt) | 1652591-80-4 |
| BRD4 Inhibitor-10 | BRD4 INHIBITOR-10 | 1660117-38-3 |
| BMS453 | BMS453 | 166977-43-1 |
| Rodatristat ethyl | RODATRISTAT ETHYL | 1673571-51-1 |
| 6-Chloro-7-deazapurine-β-D-riboside | 6-氯-7-脱氮-9-(Β-D-呋喃核糖基)嘌呤 | 16754-80-6 |
| FzM1 | FzM1 | 1680196-54-6 |
| Venadaparib | Venadaparib | 1681017-83-3 |
| Spinosad | 刺糖菌素 | 168316-95-8 |
| NXP800 | NPX-809 | 1693734-80-3 |
| Erastin2 | 4(3H)-Quinazolinone, 2-[[4-[2-(4-chlorophenoxy)acetyl]-1-piperazinyl]methyl]-3-[4-(1-methylethoxy)[1,1'-biphenyl]-3-yl]- | 1695533-44-8 |
| Ro60-0175 | Ro 60-0175 | 169675-08-5 |
| FGFR4-IN-1 | CS-2343 | 1708971-72-5 |
| bpV(phen) trihydrate | bpV(phen) (potassium hydrate) | 171202-16-7 |
| (S,S)-TAPI-1 | TAPI-1 | 171235-71-5 |
| PB28 dihydrochloride | 化合物 T23122 | 172907-03-8 |
| Ganoderic acid DM | 灵芝酸DM | 173075-45-1 |
| TC-E 5003 | N,N'-[磺酰基二(4,1-亚苯基)]二(2-氯乙酰胺) | 17328-16-4 |
| YM-244769 dihydrochloride | YM-244769二盐酸盐 | 1780390-65-9 |
| RN-1 dihydrochloride | RN1; RN 1 | 1781835-13-9 |
| Cudetaxestat | 化合物CUDETAXESTAT | 1782070-21-6 |
| N-Methyl-DL-aspartic acid | 甲基天冬氨酸 | 17833-53-3 |
| GX-201 | GX 201 | 1788071-27-1 |
| Nav1.7-IN-3 | NAV1.7-IN-3 | 1788872-06-9 |
| DiMNF | 3',4'-DiMethoxy-α-naphthoflavone | 14756-24-2 |
| TAK-915 | TAK-915 | 1476727-50-0 |
| Benzarone | 苯扎隆 | 1477-19-6 |
| Niazinin | Niazinin | 147821-57-6 |
| PXS-4728A | PXS 4728A | 1478364-68-9 |
| (rel)-β-Tocopherol | β-生育酚 | 148-03-8 |
| PF-04885614 | 1-Methyl-1-[4-(4-trifluoromethoxy-phenyl)-1H-imidazol-2-yl]-ethylamine | 1480833-70-2 |
| o-Vanillin | 邻香草醛 | 148-53-8 |
| NE-100 hydrochloride | N,N-二乙基-2-(4-甲氧基-3-苯乙基氧基苯基)乙胺盐酸盐 | 149409-57-4 |
| Sofosbuvir impurity K | 索非布韦杂质B | 1496552-51-2 |
| DL-Pyroglutamic acid | DL-焦谷氨酸 | 149-87-1 |
| Lurtotecan | 勒托替康 | 149882-10-0 |
| Peginterferon alfa-2b | 6-苄基-1-(乙氧基甲基)-5-异丙基尿嘧啶 | 149950-60-7 |
| Cholesteryl hemisuccinate | 胆固醇琥珀酸单酯 | 1510-21-0 |
联系方式
